Ericka Wiebe

Dr. Ericka Wiebe


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2023 in Radiotherapy and Oncology
Verified
Journal Article
Open access
SSSofia Spampinato
Sofia Spampinato
KTKari Tanderup
Kari Tanderup
JLJacob C. Lindegaard
Jacob C. Lindegaard
MSMaximilian P. Schmid
Maximilian P. Schmid
ASAlina Sturdza
Alina Sturdza
KKKathrin Kirchheiner
Kathrin Kirchheiner
To quantify the association of persistent morbidity with different aspects of quality of life (QOL) in locally advanced cervical cancer (LACC) survivors. Longitudinal outcome from the EMBRACE-I study was evaluated. Patient-reported symptoms and QOL were prospectively scored (EORTC-C30/CX24) at baseline and regular follow-ups. Physician-assessed symptoms were also reported (CTCAEv.3). Persistent symptoms were defined if present in at least half of the follow-ups. QOL items were linearly transformed into a continuous scale. Linear mixed-effects models (LMM) were applied to evaluate and quantify the association of persistent symptoms with QOL. Overall QOL deterioration was evaluated by calculating the integral difference in QOL over time obtained with LMM for patients without and with persistent symptoms. Out of 1416 patients enrolled, 741 with baseline and ≥ 3 late follow-ups were analyzed (median 59 months). Proportions of persistent EORTC symptoms ranged from 21.8 % to 64.9 % (bowel control and tiredness). For CTCAE the range was 11.3-28.6 % (limb edema and fatigue). Presence of any persistent symptom was associated with QOL, although with varying magnitude. Role functioning and Global health/QOL were the most impaired aspects. Fatigue and pain showed large differences, with reductions of around 20 % for most of the QOL aspects. Among organ-related symptoms, abdominal cramps showed the largest effect. Persistent symptoms are associated with QOL reductions in LACC survivors. Organ-related symptoms showed smaller differences than general symptoms such as fatigue and pain. In addition to optimizing treatment to minimize organ-related morbidity, effort should be directed towards a more comprehensive and targeted morbidity management.

21 September 2022 in Clinical Oncology
Verified
Journal Article
Closed access
KPK. Paulson
K. Paulson
NLN. Logie
N. Logie
GHG. Han
G. Han
DTD. Tilley
D. Tilley
GMG. Menon
G. Menon
EWEricka Wiebe
Ericka Wiebe

28 May 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
SZSean Zhu
Sean Zhu
EWEricka Wiebe
Ericka Wiebe
HFHaley Danielle Frerichs
Haley Danielle Frerichs
SGSunita Ghosh
Sunita Ghosh
JGJasmine Gill
Jasmine Gill
SPSophia Pin
Sophia Pin
Background: Minimally invasive surgery is widely used in endometrial cancer management, but recurrence remains a concern. Methods: A retrospective review of 1201 patients treated from 2012 to 2019 with robotic laparoscopy was conducted. Recurrence-free survival and hazard ratios were calculated using multivariate Cox models. Results: Of 1278 patients, 155 cases of recurrent disease were identified. Age (HR 1.01, p = 0.045), LVSI (HR 3.54, p < 0.001), stage and high-grade histology (HR 3.39, p < 0.001) were associated with increased risk of recurrence. Hazard ratios for stages IB, II and III/IV were 1.92 (p = 0.007), 2.67 (p = 0.001), and 3.23 (p < 0.001) respectively. The use of a uterine manipulator was an independent risk factor on multivariate analysis (HR 2.12, p < 0.001). Adjuvant chemotherapy (HR 0.67, p = 0.239) and radiotherapy (HR 0.64, p = 0.056) trends favored reduced risk but were not significant. Chemoradiotherapy was found to have a reduction in recurrence with a HR 0.44 (p = 0.002). Conclusions: Traditional prognostic factors remain important for patients with endometrial cancer having undergone robotic laparoscopic hysterectomy. Uterine manipulator use should be carefully reconsidered in endometrial cancer surgery.

16 October 2013
Verified
Book Chapter
Closed access
PDF file
EWEricka Wiebe
Ericka Wiebe
JVJacobus van der Velden
Jacobus van der Velden
GTGillian Thomas
Gillian Thomas